Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02708680
Recruitment Status : Completed
First Posted : March 15, 2016
Last Update Posted : May 16, 2022
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Syndax Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 10, 2021
Actual Study Completion Date : March 10, 2021